Hosted on MSN2h
Studies Point to Several Options for Ulcerative Colitis After Anti-TNF Failure
Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...
Healio1d
Stelara, Entyvio have ‘comparable’ cardiovascular safety profiles in older adults with IBD
Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...
The American Journal of Managed Care2d
Abstracts Highlight Access Barriers, CV Risks Associated With IBD Care
Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...
Hosted on MSN1mon
Vedolizumab Maintenance Safe and Effective for Kids With IBD
Maintenance treatment with vedolizumab (Entyvio) appeared to be safe and effective in children with inflammatory bowel disease (IBD), with greater effectiveness in those with ulcerative colitis ...
pharmaphorum3d
AbbVie breaks new ground for IL-23 drug Skyrizi in IBD
AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first ... and Takeda Pharma’s α4β7 inhibitor Entyvio (vedolizumab), both of which are ...
MedPage Today4d
Major Heart Risks Similar With Two IBD Drugs in Older Adults
For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...
Healio3d
Most patients with IBD ‘still experience significant challenges’ accessing, affording care
Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...
Reading Eagle3y
Use of Takeda’s Entyvio SC in Inflammatory…
known as Entyvio SC, Spherix captured the initial impact of the launch on the EU5 Crohn’s disease (CD) and ulcerative colitis (UC) markets through their RealTime DynamixTM services. The latest ...